Additional Resources
These sites can help you learn more about COPD and how to manage it:
For additional information, please visit these sites or contact these organizations. The web sites listed are external to GlaxoSmithKline. GlaxoSmithKline does not have control over the content of the information provided on these web sites and therefore does not warrant their accuracy and completeness.
American Lung Association
www.lungusa.org
The American Thoracic Society
www.thoracic.org
The COPD Foundation
www.copdfoundation.org
The Global Initiative for Chronic Obstructive Lung Disease
www.goldcopd.com
National Heart Lung and Blood Institute
www.nhlbi.nih.gov
Important Safety Information About ADVAIR DISKUS 250/50
ADVAIR DISKUS 250/50 is approved for adults with COPD, including chronic bronchitis, emphysema, or both. You should only take 1 inhalation of ADVAIR twice a day. Higher doses will not provide additional benefits. People with COPD taking ADVAIR may have a higher chance of pneumonia. Call your doctor if you notice any of the following symptoms: change in amount or color of sputum, fever, chills, increased cough, or increased breathing problems.
ADVAIR may increase your risk of osteoporosis and some eye problems (cataracts or glaucoma). You should have regular eye exams. Thrush in the mouth and throat may occur. Tell your doctor if you have a heart condition or high blood pressure before taking ADVAIR. Do not use ADVAIR with long-acting beta2-agonists for any reason. ADVAIR does not replace fast-acting inhalers for sudden symptoms.
